8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To develop standards and recommendations for transitional care for young people (YP) with juvenile-onset rheumatic and musculoskeletal diseases (jRMD). The consensus process involved the following: (1) establishing an international expert panel to include patients and representatives from multidisciplinary teams in adult and paediatric rheumatology; (2) a systematic review of published models of transitional care in jRMDs, potential standards and recommendations, strategies for implementation and tools to evaluate services and outcomes; (3) setting the framework, developing the process map and generating a first draft of standards and recommendations; (4) further iteration of recommendations; (5) establishing consensus recommendations with Delphi methodology and (6) establishing standards and quality indicators. The final consensus derived 12 specific recommendations for YP with jRMD focused on transitional care. These included: high-quality, multidisciplinary care starting in early adolescence; the integral role of a transition co-ordinator; transition policies and protocols; efficient communications; transfer documentation; an open electronic-based platform to access resources; appropriate training for paediatric and adult healthcare teams; secure funding to continue treatments and services into adult rheumatology and the need for increased evidence to inform best practice. These consensus-based recommendations inform strategies to reach optimal outcomes in transitional care for YP with jRMD based on available evidence and expert opinion. They need to be implemented in the context of individual countries, healthcare systems and regulatory frameworks.

          Related collections

          Author and article information

          Journal
          Ann. Rheum. Dis.
          Annals of the rheumatic diseases
          BMJ
          1468-2060
          0003-4967
          Nov 01 2016
          Affiliations
          [1 ] Newcastle University, Institute of Cellular Medicine (Rheumatology), Newcastle, UK.
          [2 ] Children's University hospital Charité, Campus Virchow, SPZ, Berlin, Germany.
          [3 ] Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.
          [4 ] Paediatric Rheumatology Unit, Hospital Infantil Universitario "Niño Jesús", Madrid, Spain.
          [5 ] Hospital Cí-nico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IDISSC), Madrid, Madrid, Spain.
          [6 ] Health Sciences, Universidad Camilo José Cela, Madrid, Madrid, Spain.
          [7 ] University of Manchester, Centre for Musculoskeletal Research, Manchester, Manchester, UK.
          [8 ] Immunology and Infectiology, Erasmus MC-Sophia, Rotterdam, The Netherlands.
          [9 ] Karolinska Universitetssjukhuset, Stockholm, Sweden.
          [10 ] Department of Paediatrics/Paediatric Rheumatology, Erasmus MC Sophia Children's Hospital Rotterdam, Rotterdam, The Netherlands.
          [11 ] Pediatric Immunology, University Hospital Gasthuisberg, Leuven, Belgium.
          [12 ] University of Leeds, School of Healthcare, Leeds, UK.
          [13 ] University of Sheffield, School of Health and Related Research, Sheffield, Sheffield, UK.
          [14 ] Paediatric Rheumatology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Newcastle upon Tyne, UK.
          [15 ] London, UK.
          [16 ] Pediatria II, Universita degli Studi di Genova Scuola di Scienze Mediche e Farmaceutiche, Genova, Liguria, Italy.
          [17 ] Department of Pediatrics, Semmelweis Egyetem, Budapest, Hungary.
          [18 ] Transitionssprechstunde am Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität München, Munchen, Germany.
          [19 ] Gulhane Military Medical Academy, School of Nursing, Ankara, Turkey, Ankara, Turkey.
          [20 ] Division of Rheumatology, Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
          [21 ] Gulhane Military Medical Faculty, Pediatric Rheumatology Unit, FMF Arthritis Vasculitis and Orphan Disease Research in Pediatric Rheumatology (FAVOR), Etlik, Ankara 06018, Turkey, Ankara, Turkey.
          [22 ] Pediatric Rheumatology, Hacettepe University Medical Faculty, Ankara, Turkey.
          [23 ] Instituto de Salud Musculoesquelética, Madrid, Spain.
          Article
          annrheumdis-2016-210112
          10.1136/annrheumdis-2016-210112
          27802961
          c176338a-eb33-4368-b534-94d51d980be7
          History

          Health services research,Juvenile Idiopathic Arthritis,Multidisciplinary team-care,Quality Indicators

          Comments

          Comment on this article